Dyslipidaemia and the progression of renal disease in chronic renal failure patients

Nephrology Dialysis Transplantation

Volumn 14, Issue 10, 1999, Pages 2392-2397

  Massy, Ziad A ^a   Khoa, Thao Nguyen ^a   Lacour, Bernard ^a   Descamps Latscha, Béatrice ^a   Man, Nguyen Khoa ^a   Jungers, Paul ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Chronic renal failure; Creatinine clearance; Fibrinogen; Homocyst(e)ine; Lipids; Lipoprotein(a)

Indexed keywords

ANTIHYPERTENSIVE AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN; HOMOCYSTEINE; LIPID; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CHRONIC KIDNEY FAILURE; CREATININE CLEARANCE; DISEASE COURSE; DYSLIPIDEMIA; FEMALE; FIBRINOGEN BLOOD LEVEL; FOLLOW UP; GENDER; HEMODIALYSIS; HOMOCYSTINURIA; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INTERSTITIAL NEPHRITIS; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEPHROSCLEROSIS; PRIORITY JOURNAL; PROTEINURIA; RISK; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; COHORT STUDIES; CREATININE; DISEASE PROGRESSION; FEMALE; HUMANS; HYPERLIPIDEMIAS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; PROTEINURIA; RISK FACTORS;

EID: 0032873179     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/14.10.2392     Document Type: Article

References (29)

1. Massy ZA, Kasiske BL. Hyperlipidemia and its management in renal disease. Curr Opin Nephrol Hypertens 1996; 5(2): 141-146
2. Moorhead JF, Chan MK, El Nahas M, Varghese Z. Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet 1982; ii: 1309-1311
3. Keane WF. Lipids and the kidney. Kidney Int 1994; 46: 910-920
4. Cappelli P, Evangelista M, Bonomini M, Palmieri PF, Albertazzi A. Lipids in the progression of chronic renal failure. Nephron 1992; 62: 31-35
5. Krolewski AS, Warram JH, Christlieb AR. Hypercholesterolemia - a determinant of renal function loss and deaths in IDDM patients with nephropathy. Kidney Int 1994; 45 [Suppl. 45]: S125-S131
6. Ravid M, Neumann L, Lishner M. Plasma lipids and the progression of nephropathy in diabetes mellitus type II: effect of ACE inhibitors. Kidney Int 1995; 47: 907-910
7. Samuelsson O, Aurell M, Knight-Gibson C, Alaupovic P, Attman P-O. Apolipoprotein-B-containing lipoproteins and the progression of renal insufficiency. Nephron 1993; 63: 279-285
8. Mulec H, Johnsen SA, Wiklund O, Björck S. Cholesterol: a renal risk factor in diabetic nephropathy? Am J Kidney Dis 1993; 22: 196-201
9. Wirta O, Pasternack A, Laippala P, Turjanmaa V. Glomerular filtration rate and kidney size after six years disease duration in non-insulin-dependent diabetic subjects. Clin Nephrol 1996; 45(1): 10-17
10. Mänttäri H, Tiula E, Alikoski T, Manninen V. Effects of hypertension and dyslipidemia on the decline in renal function. Hypertension 1996; 26: 670-675
11. Klag MJ, Whelton PK, Randall B, Neaton J, Brancatti FL, Stamler J. Serum cholesterol and ESRD incidence in men screened for the MRFIT. J Am Soc Nephrol 1996; 6: 393 (Abstract)
12. Modification of Diet in Renal Disease Study Group, Hunsicker LG, Adler S, Caggiula A et al. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney Int 1997; 51: 1908-1919
13. Samuelsson O, Mulec H, Knight-Gibson C et al. Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency. Nephrol Dial Transplant 1997; 12: 1908-1915
14. Jungers P, Massy ZA, Nguyen Khao T et al. Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: a prospective study. Nephrol Dial Transplant 1997; 12: 2597-2602
15. Gault MH, Longerich LL, Harnett JD, Wesolowski C. Predicting glomerular function from adjusted serum creatinine. Nephron 1992; 62: 249-256
16. Walser M. Progression of chronic renal failure in man. Kidney Int 1990; 37: 1195-1210
17. Maroni BJ, Steinman TI, Mitch WE. A method for estimating nitrogen intake of patients with chronic renal failure. Kidney Int 1985; 27: 58-65
18. Massy ZA, Bader CA, Chevalier A et al. Serum lipoprotein (a) levels in chronic renal failure and renal transplant patients. J Nephrol 1994; 7: 229-236
19. Massy ZA, Chadefaux-Vekemans B, Chevalier A et al. Hyperhomocysteinaemia: a significant risk factor for cardiovascular disease in renal transplant recipients. Nephrol Dial Transplant 1994; 9: 1103-1108
20. Samuelsson O, Attman P-O, Knight-Gibson C et al. Plasma levels of lipoprotein(a) do not predict progression of human chronic renal failure. Nephrol Dial Transplant 1996; 11: 2237-2243
21. Stenvinkel P, Alvestrand A, Bergström J. Factors influencing progression in patients with chronic renal failure. J Intern Med 1989; 226: 183-188
22. Locatelli F, Marcelli D, Comelli M et al. Proteinuria and blood pressure as causal components of progression to end-stage renal failure. Nephrol Dial Transplant 1996; 11: 461-467
23. Ruggenenti P, Perna A, Mosconi L et al. Proteinuria predicts end-stage renal failure in non-diabetic chronic nephropathies. Kidney Int 1997; 52 [Suppl.]: S54-S57
24. Remuzzi G. Abnormal protein traffic through the glomerular barrier induces proximal tubular cell dysfunction and causes renal injury. Curr Opin Nephrol Hypertens 1995; 4: 339-342
25. Jungers P, Hannedouche T, Itakura Y, Albouze G, Descamps-Latscha B, Man NK. Progression rate to end-stage renal failure in non-diabetic kidney diseases :a multivariate analysis of determinant factors. Nephrol Dial Transplant 1995; 10: 1353-1360
26. Williams PS, Fass G, Bone JM. Renal pathology and proteinuria determine progression in untreated mild/moderate chronic renal failure. Q J Med 1988; 67: 343-354
27. Choukroun G, Itakura Y, Albouze G et al. Factors influencing progression of renal failure in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 1995; 6: 1634-1642
28. Klahr S, Levey AS, Beck GJ et al. The effects of dietary protein restriction and blood pressure control on the progression of chronic renal disease. N Engl J Med 1994; 330: 877-884
29. Maschio G, Alberti D, Janin G et al. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N Engl J Med 1996; 334: 939-945